Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77M Series E funding round, bringing its total raised to $140M since the business was founded back in 2011.
The company, which applies AI to DNA sequencing to enable what it dubs “data-driven medicine”, last closed a $30M Series D in fall 2017.
The Series E was led by Generation Investment Management. Also investing: European private equity firm, Idinvest Partners. Existing investors, including
Read More At Article Source | Article Attribution
The post Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine” appeared first on RocketNews | Top News Stories From Around the Globe.